[ET Net News Agency, 13 August 2025] HANSOH PHARMA (03692) rose 3% to HK$37.2.
It hits an intra-day high of HK$37.2, and an intra-day low of HK$35.96. The total shares
traded was 3.67 million, with a value of HK$133.53m. The active buy/sell ratio is 64:36,
with net buying turnover of HK$26.04m. GOLDMAN SACHS (ASIA) SEC accounts for greatest net
responsive buying turnover of HK$9.17m, with volume weighted average price of HK$36.861.
J.P. MORGAN BRO (HK) accounts for greatest net responsive selling turnover of HK$8.21m,
with volume weighted average price of HK$36.904. The stock has risen a combined 5.3% over
the past 4 consecutive trading days.
The Hang Seng Index now rose 366 points, or 1.5% to 25,336.

Basic Information
=================

----------------------------------
Nominal 37.200 % Chg +3.05%
High 37.200 Low 35.960
Shares Tr 3.67m Turnover 133.53m
10-D SMA 35.733 %H.V 42.383
20-D SMA 35.644 VWAP 36.360
50-D SMA 32.008 RSI14 66.017
----------------------------------
Status: Active buy/sell ratio is 64:36, with net buying turnover of HK$26.04m, rising a
combined 5.3% over the past 4 consecutive trading days

Performance of stocks in the same sector or of relevance
========================================================

Stock (Code) Price (HK$) Change (%)
-----------------------------------------------
HANSOH PHARMA (03692) 37.20 +3.05
CSPC PHARMA (01093) 10.33 +2.89
SINOPHARM (01099) 19.21 +0.84
SINO BIOPHARM (01177) 7.59 +1.34
INNOVENT BIO (01801) 90.95 +4.18
WUXI BIO (02269) 30.28 +2.44
WUXI APPTEC (02359) 104.10 +4.00
CHINARES PHARMA (03320) 5.26 +0.38
BEIGENE (06160) 178.00 +3.61
AKESO (09926) 155.10 -0.89
-----------------------------------------------
(ed)